CCCC vs VRTX: Which Stock is Better?

Side-by-side comparison of C4 Therapeutics Inc and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

CCCC

C4 Therapeutics Inc

$2.97

VRTX

Vertex Pharmaceuticals Inc

$430.29

Key Metrics Comparison

MetricCCCCVRTXWinner
Market Cap$299.56M$110.67BVRTX
P/E RatioN/A28.40VRTX
EPS (TTM)$N/A$15.32VRTX
Revenue Growth1.1%0.1%CCCC
Gross Margin75.0%53.7%CCCC

Analyze CCCC

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CCCC or VRTX a better investment?

Comparing CCCC and VRTX: C4 Therapeutics Inc has a market cap of $299.56M while Vertex Pharmaceuticals Inc has $110.67B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CCCC and VRTX?

CCCC (C4 Therapeutics Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CCCC or VRTX?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: CCCC or VRTX?

CCCC has higher revenue growth at 1.1% vs 0.1% for VRTX.

Which company is more profitable: CCCC or VRTX?

C4 Therapeutics Inc (CCCC) has higher gross margins at 75.0% compared to 53.7% for VRTX.

Which is the larger company: CCCC or VRTX?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $110.67B compared to $299.56M for CCCC.

Should I buy CCCC or VRTX in 2026?

Both CCCC and VRTX have investment merit. CCCC trades at $2.97 while VRTX trades at $430.29. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CCCC and VRTX stock?

Key differences: Market Cap ($299.56M vs $110.67B), P/E Ratio (N/A vs 28.4x), Revenue Growth (1.1% vs 0.1%), Gross Margin (75.0% vs 53.7%).

Popular Stock Comparisons